RRML - HIV tropism and its implications for antiretroviral therapy

Main page
News
RJLabM Credits
Archive
- Current issue
- Ahead of print
- List of published issues
- 2024
  - Nr.4/2024
  - Nr.3/2024
  - Nr.2/2024
  - Nr.1/2024
  - Supplement 1/2024
- 2023
  - Nr.4/2023
  - Nr.3/2023
  - Nr.2/2023
  - Nr.1/2023
  - Supplement 1/2023
- 2022
  - Nr.4/2022
  - Nr.3/2022
  - Nr.2/2022
  - Nr.1/2022
  - Supplement 1/2022
- 2021
  - Nr.4/2021
  - Nr.3/2021
  - Nr.2/2021
  - Nr.1/2021
- 2020
  - Nr.4/2020
  - Nr.3/2020
  - Nr.2/2020
  - Nr.1/2020
  - Supplement 1/2020
- 2019
  - Nr.4/2019
  - Nr.3/2019
  - Nr.2/2019
  - Nr.1/2019
  - Supplement 1/2019
- 2018
  - Nr.4/2018
  - Nr.3/2018
  - Nr.2/2018
  - Nr.1/2018
  - Supplement 1/2018
  - Supplement 2/2018
  - Supplement 3/2018
- 2017
  - Nr.4/2017
  - Nr.3/2017
  - Nr.2/2017
  - Nr.1/2017
  - Supplement 1/2017
- 2016
  - Nr.4/2016
  - Nr.3/2016
  - Nr.2/2016
  - Nr.1/2016
  - Supplement 1/2016
- 2015
  - Nr.4/2015
  - Nr.3/2015
  - Nr.2/2015
  - Nr.1/2015
  - Supplement 1/2015
- 2014
  - Nr.4/2014
  - Nr.3/2014
  - Nr.2/2014
  - Nr.1/2014
  - Supplement 1/2014
- 2013
  - Nr.4/2013
  - Nr.3/2013
  - Nr.2/2013
  - Nr.1/2013
  - Supplement 1/2013
- 2012
  - Nr.4/2012
  - Nr.3/2012
  - Nr.2/2012
  - Nr.1/2012
  - Supplement 1/2012
- 2011
  - Nr.4/2011
  - Nr.3/2011
  - Nr.2/2011
  - Nr.1/2011
  - Supplement 1/2011
- 2010
  - Nr.4/2010
  - Nr.3/2010
  - Nr.2/2010
  - Nr.1/2010
  - Supplement 1/2010
- 2009
  - Nr.4/2009
  - Nr.3/2009
  - Nr.2/2009
  - Nr.1/2009
  - Supplement 1/2009
- 2008
  - Nr.4/2008
  - Nr.3/2008
  - Nr.2/2008
  - Nr.1/2008
  - Supplement 1/2008
- 2007
  - Nr.4/2007
  - Nr.3/2007
  - Nr.2/2007
  - Nr.1/2007
- 2006
  - Nr.4/2006
  - Nr.3/2006
  - Nr.2/2006
  - Nr.1/2006
- 2005
  - Nr.1/2005
Instructions for authors
Online applications
- Send an article
- Online payments
Editorial
About us
Links

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Top 10 downloaded articles - December 2024 -

Investigation of cytokine chan...	3
A comprehensive review of glyc...	2
Role of Th1/Th2 imbalance medi...	2
Towards appropriate training f...	2
HIV tropism and its implicatio...	1
Vitamin K and bone metabolism...	1
The influence of UV-A radiatio...	1
Quality Control for Chemistry ...	1
Nuclear Magnetic Resonance Spe...	1
Alpha-methylacyl-CoA-racemase ...	1

Concept, Design & Programming
Dr. Adrian Man

Nr. 19(1)/2011

HIV tropism and its implications for antiretroviral therapy

Carmen L. Chiriac, Marta A. Fodor, Nina I. Şincu

Abstract:

Viral tropism defines the feature of HIV isolates to use a certain CCR5, CXCR4 coreceptor in order to enter CD4 positive, receptor cells. The dynamics of the HIV tropism plays a major role in the pathogenesis of the HIV infection and influences the progression of the disease. HIV tropism correlates with the epidemiology of HIV-1 subtypes and can be modified by the antiretroviral complex therapy. Coreceptor antagonists CCR5 (CXC4) represent a new generation of molecules used in the therapy of HIV infection, in multi-experienced patients as well as in naïve individuals. Maraviroc is the only drug from the class of coreceptor antagonists approved for the treatment of CCR5 tropic HIV-1 infected patients. In order to determine the susceptibility of an HIV-1 population to CCR5 antagonists, viral tropism testing is indispensable. Several phenotype and genotype tests were developed to identify the tropism of the HIV-1 isolates. The clinically approved method is Trofile, certified according to the specifications of the Clinical Laboratory Improvement Amendments (CLIA).

Keywords: CCR5,CXCR4 coreceptors,HIV-1 tropism,coreceptor antagonists

Download full text PDF
(115 KB)

Chiriac CL, Fodor MA, Şincu NI. HIV tropism and its implications for antiretroviral therapy. Rev Romana Med Lab. 2011;19(1):7-15